Masaryk Memorial Cancer Institute
17
6
6
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Pancreatic Cancer Screening in a Population at High Risk
Role: lead
Cancer Survivors Program
Role: lead
Acupuncture as the Therapeutic Modalities of Acute Toxicity in the Radiotherapy of Head and Neck Tumors
Role: lead
11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET)
Role: lead
Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis
Role: collaborator
FMISO-based Adaptive Radiotherapy for Head and Neck Cancer
Role: collaborator
Early Detection of Malnutrition in Oncology Patients and Elderly Patients
Role: collaborator
Vancomycin and Negative Pressure Therapy for Post-sternotomy Deep Sternal Wound Infection
Role: collaborator
Optimization of Fractionation Schedules of Heel Spur Radiotherapy Prospective Randomized Open-label Trial
Role: lead
Effectiveness and Suitability of the Online Mobile Application for the Mental and Physical Health of Cancer Patients
Role: collaborator
The Effectiveness of Psychological Interventions in Psycho-neuroendocrine-immune Network in Breast Cancer Survivors
Role: collaborator
Ideal Marker for Targeted Axillary Dissection
Role: collaborator
Adjuvant Partial-breast Irradiation Using Stereotactic Body Radiation Therapy
Role: lead
Prostate Cancer Screening With Abbreviated MRI Protocol
Role: lead
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization
Role: collaborator
Antibody Detection in COVID-19 Cured Patients (SARS-CoV-2-CZ-Immunity)
Role: collaborator
COVID-19: Herd Immunity Study in the Czech Republic
Role: collaborator
All 17 trials loaded